All Pharma News
Fyodor Urnov want to streamline gene editing studies with Danaher`s help

Fyodor Urnov want to streamline gene editing studies with Danaher`s help
Lei Lei Wu ENDPTS
09 Jan 2024
Share Share
Danaher completes $5.7 billion acquisition of Abcam

Danaher completes $5.7 billion acquisition of Abcam
Khushi Mandowara REUTERS
07 Dec 2023
Share Share
Shareholders of Abcam Approve Proposed Acquisition by Danaher

Shareholders of Abcam Approve Proposed Acquisition by Danaher
PRESS RELEASE
07 Nov 2023
Share Share
Danaher’s third-quarter revenue from biotech services down 19% amid slowdown

Danaher’s third-quarter revenue from biotech services down 19% amid slowdown
Ayisha Sharma ENDPTS
25 Oct 2023
Share Share
Glass Lewis Joins ISS in Recommending Vote “FOR” Danaher’s Proposed Acquisition of Abcam

Glass Lewis Joins ISS in Recommending Vote “FOR” Danaher’s Proposed Acquisition of Abcam
BUSINESSWIRE
23 Oct 2023
Share Share
Abcam lays out details behind $5.7B Danaher acquisition

Abcam lays out details behind $5.7B Danaher acquisition
Katherine Lewin ENDPTS
06 Oct 2023
Share Share
Life sciences firm Danaher to buy Abcam in $5.7 bln deal

Life sciences firm Danaher to buy Abcam in $5.7 bln deal
Manas Mishra REUTERS
29 Aug 2023
Share Share
Danaher’s Aldevron unit plots mRNA manufacturing expansion

Danaher’s Aldevron unit plots mRNA manufacturing expansion
FIERCE PHARMA
01 May 2023
Share Share
Danaher approached contract manufacturer Catalent about acquisition

Danaher approached contract manufacturer Catalent about acquisition
Tyler Patchen ENDPTS
06 Feb 2023
Share Share
Sysmex, Danaher Settle Blood-Analyzer Patents Suit Before Trial

Sysmex, Danaher Settle Blood-Analyzer Patents Suit Before Trial
BLOOMBERGLAW
17 Oct 2022
Share Share